Not Yet Recruiting
Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza
NCT06817096
- Conditions
- COVID 19, COVID-19, Coronaviridae Infections, +13 more
- Locations
-
Not specified